(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Attention Deficit/Hyperactivity Disorder (ADHD - Adults)
This is a study of reaction time, decision-making, and simulated driving for adults with ADHD.
If you are between the ages of 19 and 26 and have ever been diagnosed with ADHD or ADD or sought medical treatment for problems related to these conditions, you may qualify for this study.
The research site is in Lexington, Ky.
More information
Please see http://www.centerwatch.com/patient/studies/cat499.html.
-----
Hypertension (High Blood Pressure)
This is a clinical research study to find out if the combination of the drugs valsartan and amlodipine is safe and effective for African-Americans with moderate-to-severe high blood pressure.
Successful applicants for this trial should be African-Americans 18 years old or older who have stage 2 hypertension (systolic blood pressure of less than 200 mmHg but greater than or equal to 160 mmH). Participants must not have any known or suspected allergy or hypersensitivity to blood pressure medications in the same classes as valsartan, amlodipine or HCTZ, nor any history of any heart conditions.
The research sites are located in Puerto Rico and across the United States.
More information
Please see http://www.centerwatch.com/patient/studies/cat85.html.
-----
Asthma
A research study is being conducted that looks at the safety and effectiveness of an investigational non-drug outpatient procedure in a population of subjects with moderate-to-severe asthma who still experience asthma symptoms despite being managed with conventional therapy.
This research study involves up to 14 visits over the first 14 months and 1 visit per year for 4 additional years in a select group of subjects.
To be eligible to participate, you must be between the ages of 18 and 65 and currently using inhaled steroids.
The research site is in Denver, Colo.
More information
Please see http://www.centerwatch.com/patient/studies/cat16.html.
-----
Copyright 2006 Thomson CenterWatch. All rights reserved.
